Compare Stocks → Gold Set to EXPLODE! (From Gold Safe Exchange) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison CVE:ICO Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeICOiCo TherapeuticsC$0.11C$0.11C$0.02▼C$0.16C$952KN/A3.16 million shs1.31 million shs7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceICOiCo Therapeutics0.00%0.00%0.00%0.00%0.00%Gold Set to EXPLODE! (Ad)Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide!MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationICOiCo TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceICOiCo TherapeuticsN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookICOiCo TherapeuticsN/AN/AC$0.01 per share8.75C$0.00 per shareN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateICOiCo TherapeuticsN/A-C$0.01N/A∞N/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthICOiCo TherapeuticsN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioICOiCo TherapeuticsN/A1.141.12OwnershipInstitutional OwnershipCompanyInstitutional OwnershipICOiCo TherapeuticsN/AInsider OwnershipCompanyInsider OwnershipICOiCo TherapeuticsN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableICOiCo TherapeuticsN/A9.07 millionN/ANot OptionableICO, MTPH, LCT, and MEB HeadlinesSourceHeadlineX Factor legend to star in musical about Gwyneth Paltrow’s ski crashmsn.com - May 8 at 6:16 PMCara Delevingne forced to deny being ‘coked up’ after awkward red carpet interviewmsn.com - May 8 at 8:52 AMThe moment ‘completely broken’ Dannii Minogue wanted to ‘run’ from The X Factormetro.co.uk - May 6 at 8:07 AMX Factor star ‘attacked and mugged’ in unsettling incidentmsn.com - May 3 at 8:38 AMX Factor legend hasn’t aged a day 19 years after controversial exitmsn.com - May 1 at 6:21 PMCancer jab marks huge breakthrough in battle against deadly brain tumoursmsn.com - May 1 at 1:20 PMZelda director wants to make ‘grounded’ movie with less motion capturemsn.com - May 1 at 8:19 AMX Factor legend responds to ‘satanic panic’ over drastic new lookmetro.co.uk - April 30 at 10:14 PMX Factor legend has best response after bizarre ‘satanic’ criticism over her transformationmetro.co.uk - April 30 at 5:04 PMX Factor legend hits back at critics over ‘half-naked’ new lookmetro.co.uk - April 30 at 8:18 AMCara Delevingne’s house fire mystery deepens as investigators issue official rulingmetro.co.uk - April 29 at 9:14 AMZelda: Tears Of The Kingdom is a chore and has no respect for your time – Reader’s Featuremsn.com - April 26 at 10:48 PMCalifornia Nurses Associationdigitalhealth.net - April 26 at 7:48 AM‘The moment I knew I would never speak to Sharon Osbourne again after X Factor’msn.com - April 24 at 3:33 PMRylan Clark reveals ‘honest truth’ behind X Factor auditionmetro.co.uk - April 19 at 8:59 PMX Factor winner releases surprise new single with global superstar singermsn.com - April 19 at 3:53 PMEnlivex Therapeutics Ltd (ENLV)investing.com - April 17 at 2:28 PMIs Covid still a threat four years on from the first wave?msn.com - April 14 at 2:40 PMCara Delevingne sparks backlash over lack of ‘trigger warning’ after revealing horrifying TV show birthmetro.co.uk - April 14 at 9:40 AMThe next Zelda game should be spin-off without Link – Reader’s Featuremsn.com - April 13 at 12:36 AMMinishoot’ Adventures review – Zelda in a spaceshipmsn.com - April 12 at 2:35 PMX Factor legends Jedward say Louis Walsh ‘took advantage’ of themmsn.com - April 9 at 3:37 PMX Factor star Megan McKenna reveals ‘secret’ pregnancy with first child months after getting engagedmetro.co.uk - April 4 at 7:57 PMX Factor star announces engagement and reveals Simon Cowell’s huge role at weddingmsn.com - March 31 at 6:27 PMMedia Sentiment Over TimeTop HeadlinesNXP Semiconductors Will Set a New High Soon: $300 in SightApril 30, 2024 11:26 AMView NXP Semiconductors Will Set a New High Soon: $300 in Sight5 Semiconductor Giants: Navigating the Recent PullbackApril 12, 2024 9:10 AMView 5 Semiconductor Giants: Navigating the Recent PullbackASML’s Earnings Could Bring The Stock to New HighsApril 16, 2024 10:20 AMView ASML’s Earnings Could Bring The Stock to New HighsMU Nears Breakout as Analysts Continue to Pound the TableMay 8, 2024 7:11 AMView MU Nears Breakout as Analysts Continue to Pound the Table5 Trends You Need to Know This QuarterApril 13, 2024 9:16 AMView 5 Trends You Need to Know This QuarterAll Headlines Company DescriptionsiCo TherapeuticsCVE:ICOiCo Therapeutics Inc., a biotechnology company, focuses on the identification, development, and commercialization of drug candidates to treat ocular and infectious diseases. Its in-licensed drug candidates include iCo-008, a human monoclonal antibody, which is in Phase II clinical trial to treat ulcerative colitis and bullous pemphigoid; and Oral AmpB Delivery System, an oral formulation of Amphotericin B that is in Phase 1b clinical trial for the treatment of systemic fungal and parasitic infections. The company was incorporated in 2005 and is headquartered in Vancouver, Canada. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
